BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29546066)

  • 21. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
    Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
    Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
    Patel PL; Suram A; Mirani N; Bischof O; Herbig U
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.
    Bae-Jump VL; Zhou C; Gehrig PA; Whang YE; Boggess JF
    Gynecol Oncol; 2006 Mar; 100(3):487-94. PubMed ID: 16249016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
    Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
    J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
    Qi Z; Mi R
    Cancer Gene Ther; 2016 Jan; 23(1):36-42. PubMed ID: 26742579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
    Gao J; Zhang J; Long Y; Lu X
    Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
    BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
    Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
    Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
    Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
    J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells.
    Xiao N; Chen S; Ma Y; Qiu J; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
    Biochem Biophys Res Commun; 2012 Mar; 419(3):567-72. PubMed ID: 22369941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of human telomerase reverse transcriptase through anti-C-myc siRNA in human colon cancer Colo 320 cells.
    Hu X; Yu N; Fu L; Su W; Huang G; Wu Y; Huang H; Huang H
    Nucleosides Nucleotides Nucleic Acids; 2009; 28(1):1-11. PubMed ID: 19116866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells.
    Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
    Cancer Lett; 2009 Dec; 286(2):172-9. PubMed ID: 19560862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
    Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
    Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics.
    Possemato R; Timmons JC; Bauerlein EL; Wada N; Baldwin A; Masutomi K; Hahn WC
    Mol Cancer Res; 2008 Oct; 6(10):1582-93. PubMed ID: 18922974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability.
    Bunch JT; Bae NS; Leonardi J; Baumann P
    Mol Cell Biol; 2005 Jul; 25(13):5567-78. PubMed ID: 15964812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. htert expression correlates with MYC over-expression in human prostate cancer.
    Latil A; Vidaud D; Valéri A; Fournier G; Vidaud M; Lidereau R; Cussenot O; Biàche I
    Int J Cancer; 2000 Mar; 89(2):172-6. PubMed ID: 10754496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.